Patient Registry for Individuals With CABP2-Associated Hearing Loss
Status: Recruiting
Location: See location...
Intervention Type: Diagnostic test
Study Type: Observational
SUMMARY
This registry is designed to collect comprehensive information about the molecular genetic diagnoses and clinical information of individuals with CABP2-associated hearing impairment to support a natural history study.
Eligibility
Participation Requirements
Sex: All
Healthy Volunteers: f
View:
• A molecular genetic diagnosis involving biallelic variants in CAPB2 and audiometry
Locations
Other Locations
Germany
University Medical Center Goettingen
RECRUITING
Göttingen
Contact Information
Primary
Barbara Vona, PhD
barbara.vona@med.uni-goettingen.de
+49-551-38-51337
Backup
Tobias Moser, MD
tmoser@gwdg.de
+49-551-39-63070
Time Frame
Start Date: 2024-08-16
Estimated Completion Date: 2049-08-16
Participants
Target number of participants: 100
Treatments
CABP2 participant group
Individuals with hearing impairment who have a molecular genetic diagnosis involving CABP2
Related Therapeutic Areas
Sponsors
Leads: University Medical Center Goettingen